Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential

Carmen Ledesma‐Feliciano(University of Colorado Anschutz Medical Campus), Martin Löchelt(German Cancer Research Center), Guochao Wei(Chinese Academy of Sciences), Jörg Zielonka(Paul Ehrlich Institut), Sue VandeWoude(Colorado State University), Daniel G. Maeda(German Cancer Research Center), Ryan M. Troyer(Western University), Esther Musselman(Colorado State University), Ann-Mareen Franke(German Cancer Research Center), Carsten Münk(Heinrich Heine University Düsseldorf), Xin Zheng(National Institute of Infectious Diseases), Dragana Slavkovic Lukic(German Cancer Research Center), Sarah Hagen(German Cancer Research Center)
Retrovirology
May 16, 2018
10.1186/s12977-018-0419-0
Cited by 18

Related Papers

Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif
|Cell|2003|891
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
|Science|2014|876
APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition
|Journal of Biological Chemistry|2006|356
Guidelines for Naming Nonprimate APOBEC3 Genes and Proteins
|Journal of Virology|2008|229
A dominant block to HIV-1 replication at reverse transcription in simian cells
|Proceedings of the National Academy of Sciences|2002|228